Effects of Delayed Cord Clamp and/or Indomethacin on Preterm Infant Brain Injury
Public ClinicalTrials.gov record NCT02221219. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Indomethacin and Delayed Umbilical Cord Clamp for Preterm Infant IVH
Study identification
- NCT ID
- NCT02221219
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- Hong Huang
- Other
- Enrollment
- 256 participants
Conditions and interventions
Interventions
- Indomethacin Drug
- delay in umbilical cord clamp at birth Procedure
- placebo infusion Drug
- immediate cord clamp at birth Procedure
Drug · Procedure
Eligibility (public fields only)
- Age range
- 24 Weeks to 30 Weeks
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2014
- Primary completion
- Oct 26, 2019
- Completion
- Aug 27, 2021
- Last update posted
- Nov 22, 2021
2014 – 2021
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Kentucky Childrens Hospital Neonatal Intensive Care Unit | Lexington | Kentucky | 40506 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02221219, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 22, 2021 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02221219 live on ClinicalTrials.gov.